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The transport of Toll-like Receptors (TLRs) to various
organelles has emerged as an essential means by
which innate immunity is regulated. While most of
our knowledge is restricted to regulators that pro-
mote the transport of newly synthesized receptors,
the regulators that control TLR transport after micro-
bial detection remain unknown. Here, we report that
the plasma membrane localized Pattern Recognition
Receptor (PRR) CD14 is required for the microbe-
induced endocytosis of TLR4. In dendritic cells, this
CD14-dependent endocytosis pathway is upregu-
lated upon exposure to inflammatory mediators.
We identify the tyrosine kinase Syk and its down-
stream effector PLCg2 as important regulators of
TLR4 endocytosis and signaling. These data estab-
lish that upon microbial detection, an upstream
PRR (CD14) controls the trafficking and signaling
functions of a downstream PRR (TLR4). This innate
immune trafficking cascade illustrates how pathogen
detection systems operate to induce bothmembrane
transport and signal transduction.
INTRODUCTION
The endocytosis of immunity-related receptors has emerged as
a critical control step in the signal transduction process. The first
receptors activated during any host-pathogen interaction are
members of the Toll-like Receptor (TLR) family, which are respon-
sible for detecting microbial products and inducing innate and
adaptive immunity (Akira and Takeda, 2004). Different TLR family
membersare found indifferent subcellular compartments, ranging
from the plasma membrane to early, late, and recycling endo-
somes (Barton and Kagan, 2009). While it was believed originally
that the endocytosis of plasma membrane-localized TLRs down-
regulates their signaling functions after amicrobial encounter (Hu-
sebye et al., 2006; Latz et al., 2003), new evidence indicates that
receptor delivery to endosomes also activates specific signal
transduction pathways (Kagan et al., 2008; Tanimura et al., 2008).868 Cell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc.Virtually all of our knowledge of TLR transport is limited to regu-
lators that promote the folding or transport of newly synthesized
receptors (e.g., GP96, PRAT4a, and UNC93B1) (Kim et al., 2008;
Takahashi et al., 2007; Yang et al., 2007). In the absence of
each of these regulators, specific sets of TLRs cannot exit the
endoplasmic reticulum after translation and, consequently, TLR
ligands present in the extracellular and endosomal spaces are
not detected. Unlike the emerging knowledge on the trafficking
of newly synthesized receptors, almost nothing is known about
the regulators that control TLR endocytosis or transport after
microbial detection. Filling this gap in our knowledge is of
fundamental importance, asmicrobe-induced receptor transport
is a critical control step in TLR-mediated signal transduction.
The first-described example of microbe-induced TLR trans-
port came from studies of the LPS receptor TLR4, which induces
distinct signaling pathways from two different organelles (Kagan
et al., 2008; Tanimura et al., 2008). The first signaling pathway is
activated from the plasma membrane after TLR4 encounters
LPS (Latz et al., 2003). This pathway is mediated by a pair of
sorting and signaling adaptor proteins called TIRAP and
MyD88, respectively (Kagan and Medzhitov, 2006). These adap-
tors induce proinflammatory cytokine expression by linking TLR4
to downstream enzymes that activate NF-kB and AP-1 (Akira
and Takeda, 2004). TLR4 is then internalized into the endosomal
network where the second signaling pathway is triggered
through the adaptors TRAM and TRIF (Kagan et al., 2008; Tani-
mura et al., 2008). These adaptors mediate the activation of
the transcription factor Interferon Regulatory Factor-3 (IRF3),
which regulates Type I Interferon (IFN) expression (Akira and
Takeda, 2004). Thus, in the case of TLR4, the LPS-induced
endocytosis of the receptor is essential for its signaling func-
tions. While the general endocytic machinery is undoubtedly
involved in internalization of plasma membrane-localized TLRs,
there are no known membrane proteins that regulate TLR endo-
cytosis specifically upon microbial recognition.
Inconsidering thisproblem,we reasoned that sinceTRIF-medi-
ated IFN expression requires TLR4 endocytosis, cell surface
proteins that control endosomal signalingmaydosoby regulating
TLR4 entry into the cell. One such regulator is CD14. CD14 is
a GPI-linked protein that is found on the surface of many (but
not all) TLR4 expressing cells (Wright et al., 1990). CD14 was
the first identified Pattern Recognition Receptor (PRR) that binds
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Figure 1. CD14 Is Required for LPS-Induced TLR4
Endocytosis
(A and B) WT or CD14-deficient (KO) mouse BMDM (A) or
DCs (B) were untreated or treated with LPS (1 mg/ml) for
the times indicated. Flow cytometry was then used to
examine receptor endocytosis by determining the surface
levels of the endogenous proteins indicated. The third and
fourth panels in (A) and (B) represent the mean fluores-
cence intensity (MFI) of specific receptor staining at each
time point.
(C and D) BMDM (C) or DCs (D) were treated with the
concentrations of LPS indicated for 18 hr and the amounts
of secreted cytokines were determined.
(E and F) BMDM (E) or DCs (F) were treated with LPS
(1 mg/ml) for the times indicated and the presence of active
(dimerized) IRF3 in cell extracts was determined by native
PAGE.
See also Figure S1.directly to LPS (Wright et al., 1990), and is known to chaperone
LPS molecules to the TLR4-MD-2 signaling complex (da Silva
Correia et al., 2001; Gioannini et al., 2004; Moore et al., 2000).
Notably, while CD14 is marginally important for MyD88-depen-
dent TNFa expression, it is essential for TRIF-mediated IFN
expression (Jiang et al., 2005). Thus, we hypothesized that
CD14 specifically regulates TRIF-mediated IFN expression
because it regulates TLR4 endocytosis. Here, we show that this
prediction is correct and that CD14 controls a microbe-specific
endocytosis pathway that functions to internalize both TLR4
and promote TRIF-mediated signal transduction. Remarkably,
TLR4 is internalized independently of its signaling functions but
dependent on regulators of Fc Receptor and Dectin-1-mediated
endocytosis. Collectively, these data suggest the existence of
an inflammatory endocytosis pathway that can be activated by
multiple upstream receptors to promote antimicrobial immunity.
RESULTS
CD14 Is Required for LPS-Induced TLR4 Endocytosis
To identify proteins that specifically regulate the LPS-induced
endocytosis of TLR4, we used a highly sensitive assay to detect
endogenous TLR4 by flow cytometry. Using the loss of cell
surface expression as a readout for TLR4 endocytosis, weCell 147, 868–showed previously that LPS induces TLR4 inter-
nalization in mouse bone marrow derived
macrophages (BMDM) (Kagan et al., 2008).
The loss of TLR4 surface staining was a bona
fide endocytic event as it was inhibited by dyna-
sore (Kagan et al., 2008), an inhibitor of dynamin
GTPases that control most endocytic processes
in mammalian cells. Using this assay, we deter-
mined if CD14 regulates TLR4 transport as
a means of controlling IFN production.
LPS-induced TLR4 endocytosis was exam-
ined in BMDM and immature dendritic cells
(DCs) from wild-type (WT) and CD14-deficient
mice. LPS induced the rapid endocytosis of
TLR4 in WT BMDM and DCs, but not in cellsfrom CD14-deficient mice (Figures 1A and 1B). The endocytosis
of TLR4 was a specific response, as levels of a different endo-
cytic receptor (FcgR1) were largely unaffected by LPS treatment
(Figures 1A and 1B). To complement this FACS-based assay,
TRIF-mediated signaling events from endosomes were exam-
ined (Kagan et al., 2008). CD14-deficient BMDM and DCs were
defective for TRIF-mediated IFN production but were not defec-
tive for MyD88-mediated TNFa production (Figures 1C and 1D).
Of note, at low LPS concentrations, CD14 was needed for TNFa
production, which likely reflects its role in delivering LPS to TLR4
(da Silva Correia et al., 2001; Gioannini et al., 2004).
Tomore specifically address the role of CD14 in signaling from
the plasma membrane or endosomes, we examined protein
complexes that define each pathway. TLR4 signaling from the
plasma membrane induces the formation of the Myddosome,
a complex containing MyD88 and IRAK4 that activates NF-kB
(Motshwene et al., 2009). TLR4 signaling from endosomes
induces the dimerization of the transcription factor IRF3 (Kagan
et al., 2008). We monitored the formation of the Myddosome
by coimmunoprecipitations of MyD88 and IRAK4 in WT and
CD14-deficient immature DCs. LPS treated WT and CD14-defi-
cient DCs induced Myddosome formation (Figure S1A available
online), suggesting that TLR4 signaling from the plasma
membrane does not absolutely require CD14. In addition,880, November 11, 2011 ª2011 Elsevier Inc. 869
CD14-deficient cells retained the ability to activate the MAP
kinasesp38andERK1/2and induce IkBadegradation in response
to LPS treatment (Figures S1B and S1C). In contrast to the
signaling events occurring at the plasma membrane, LPS-
induced dimerization of IRF3 was not detected in either CD14–
deficient BMDM or DCs (Figures 1E and 1F). Collectively, using
both direct assays of TLR4 endocytosis and assays of signaling
events that occur only after endocytosis, these data establish
that CD14 is required for LPS-induced endocytosis of TLR4.
In addition to TLR4, TLR2 signaling in inflammatorymonocytes
and BMDM can induce IFN expression (Barbalat et al., 2009;
Dietrich et al., 2010). Under these conditions, TLR2 endocytosis
is necessary for IFN expression. To determine the specificity
of the role of CD14 for TLR4-mediated IFN expression, we
examined the expression of cytokines and IFN-regulated genes
in WT and CD14-deficient cells stimulated with TLR2 ligands.
Neither inflammatory monocytes nor BMDM from CD14-defi-
cient mice displayed any defects in their responses to their
diverse TLR2 ligands (Figures S1D and S1E), indicating that
the role of CD14 in promoting IFN expression is specific to TLR4.
Cell Type-Specific Coexpression of TLR4 and CD14
Confers Cell Type-Specific Responses to LPS
While diverse cell types are LPS responsive, not all LPS-respon-
sive cells respond in the samemanner. Themolecules that dictate
cell type-specific responses to LPS are unknown. We hypothe-
sized that CD14 expression would naturally endow TLR4-bearing
cells with the ability to promote TLR4 endocytosis, thus providing
amechanismofcell type-specificcontrol over LPS-inducedactiv-
ities. Thishypothesiswasaddressedbyexamining theexpression
of CD14 in cell types that are known to express TLR4 (Hoshino
et al., 1999). BMDM, immature DCs, andmouse embryonic fibro-
blasts (MEFs) expressedCD14, but theA20Bcell linedid not (Fig-
ure 2A and Figure S2A). Analysis of TLR4-deficient cells indicated
that the surface expression of CD14 did not require TLR4 (Fig-
ure S2A). Like BMDM and immature DCs, MEFs permitted TLR4
endocytosis in response to LPS (Figure 2B). In contrast, TLR4
surface levelswere unchanged inA20Bcells, although thesecells
responded to LPS by upregulating MHC-II and CD69 (Figure 2B
andS2B). To address directly if the inability of A20 B cells to inter-
nalize TLR4 resulted from deficient CD14 expression, we trans-
fected these cells with a plasmid encoding CD14. A20 B cells
expressingCD14gained theability to internalizeTLR4 (Figure2C).
These latter results are consistent with previous work showing
that the B cell line Ba/F3 displays enhanced TLR4 endocytosis
when CD14 is overexpressed (Tanimura et al., 2008).
To determine if our results apply to conditions in vivo, WT and
CD14-deficient mice were injected intravenously with LPS and at
various times after injection, CD11c+/CD11b+ cells (DCs) or
CD11c-/CD11b+, Ly6G- cells (BMDM) or CD19+ cells (B cells)
were harvested from the spleen and examined for CD14 and
TLR4 surface levels as a readout for receptor endocytosis. Prior
to LPS injection, only DCs and BMDM (not B cells) expressed
CD14 (Figure 2D). Splenic BMDM and DCs internalized TLR4 in
response to LPS injection (Figure 2E), and this process was
dependent on CD14. In contrast, splenic B cells were not
capable of internalizing TLR4 in response to LPS injection (Fig-
ure 2E). Notably, transfection of ex vivo cultured splenic B cells870 Cell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc.with plasmids encoding CD14 endowed these cells with the
ability to internalize TLR4 (Figure 2F). Collectively, these data
establish that the natural coexpression of CD14 and TLR4 deter-
mines which cell types internalize TLR4 in response to LPS.
CD14 Mediates the LPS-Induced Internalization
of Extracellular Macromolecules
In addition to promoting TLR4 endocytosis, LPS induces DCs to
undergo rapidmacropinocytosis (West et al., 2004). To determine
if CD14 regulates this process, we examined the capture of fluo-
rescentdextransby immatureDCs,BMDM,MEFsandA20Bcells
byFACS.LPS induced rapidmacropinocytosis of dextransonly in
cells that naturallyexpressCD14 (BMDM,DCs,andMEFs,butnot
A20 B cells) (Figures 3A–3C). Moreover, CD14 was required for
LPS-induced macropinocytosis in BMDM and DCs (Figures 3A
and 3B). As expected from previous work implicating the TLR4-
activated kinase Rsk in macropinocytosis (Zaru et al., 2007),
TLR4 was required for this response (Figures 3A and 3B).
To address directly if the macropinocytosis defects of A20 B
cells results from deficient CD14 expression, we transiently
transfected these cells with plasmids encoding CD14. A20 B
cells expressing CD14 gained the ability to induce macropinocy-
tosis in response to LPS (Figure 3C). These data suggest that the
CD14-dependent endocytosis pathway functions to internalize
both TLR4 and extracellular macromolecules.
The CD14-Dependent Endocytosis Pathway Is
Upregulated upon DC Maturation
Perhaps more than any other antigen presenting cell, the func-
tions of DCs are tied to their endocytic capacity (Mellman and
Steinman, 2001). Recent work has demonstrated that mature
DCs retain the capacity to capture and present antigens on
MHC-II (Drutman and Trombetta, 2010; Platt et al., 2010). We
reasoned that if mature DCs retain the ability to capture antigens,
then they should also retain the ability to respond to microbial
products. We therefore determined if CD14-dependent activities
are retained after DC maturation.
ImmatureDCswere treatedwith either TNFaor theTLR9 ligand
CpGDNA.Each of these ligands induced the upregulation of cos-
timulatorymolecules andMHC-II inWT andCD14-deficient DCs,
indicating that DCmaturation does not require CD14 (Figure 4A).
The resulting mature cells were then stimulated with LPS to
examine TLR4 endocytosis and cytokine expression. Interest-
ingly, as compared to immature DCs, LPS-induced TLR4 endo-
cytosis was enhanced (Figure 4B). The enhancement of TLR4
endocytosis was impressive—mature DCs exhibited a faster
rate of TLR4 endocytosis, and these cells internalized a larger
percent of the total receptors (Figure 4B). This increase in TLR4
entry coincided with an increased production of TRIF-dependent
IFNs (Figure 4C), but not MyD88-dependent TNFa (Figure 4D). A
potential explanation for the maturation-induced enhancement
of TLR4 endocytosis and signaling would be if the maturation
stimuli triggered an increase in the expression of CD14. Consis-
tent with this idea, we found that TNFa or CpG DNA treatment
resulted in higher surface levels of CD14, compared to immature
DCs (Figure 4E). This increase in CD14 surface levels correlated
with an increase in CD14 gene expression (Figure 4F). The
signaling pathways triggered by CpG DNA and TNFa activate
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Figure 2. The Natural Expression Profile of CD14 Determines which Cells Undergo LPS-Induced TLR4 Endocytosis
(A) The cells indicated were examined for the expression of surface levels of endogenous CD14 by flow cytometry.
(B) MEFs and A20 B cells were treated with LPS (1 mg/ml) for the times indicated and TLR4 endocytosis was monitored by flow cytometry. Shown are the MFI of
specific TLR4 surface staining at each time point indicated.
(C) A20 B cells were transiently transfected with a plasmid encoding CD14 and treated with LPS (1 mg/ml) for the times indicated before TLR4 endocytosis was
examined by flow cytometry.
(D) DCs, BMDM, or B cells were isolated from the spleen of mice and examined for the expression of surface levels of CD14 by flow cytometry.
(E) Mice were injected with LPS (50 mg) and at the times indicated spleens were isolated and BMDM, DCs, and B cells were examined for surface levels of TLR4 by
flow cytometry.
(F) Splenic B cells were transfected with a plasmid encoding CD14 and treated for the indicated times with LPS (1 mg/ml) before TLR4 endocytosis was examined
by flow cytometry.
See also Figure S2.NF-kB (Akira and Takeda, 2004; Muppidi et al., 2004). Thus, the
NF-kB-specific inhibitor Bay11-7085 was used to examine the
role of this transcription factor in CD14 gene expression.
Bay11-7085 prevented CD14 upregulation by either CpG DNA
or TNFa (Figure 4G), suggesting that NF-kB mediates CD14expression. Moreover, MyD88-deficient cells, which are defec-
tive for CpG DNA-induced NF-kB expression (Hemmi et al.,
2000), were incapable of upregulating CD14 upon CpG DNA
treatment (Figure 4F). MyD88-deficient cells retained the ability
to induce CD14 expression in response to TNFa (Figure 4F).Cell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc. 871
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Figure 3. CD14 Is Required for LPS-Induced
Macropinocytosis
Macropinocytosis was measured in DCs (A) or BMDM (B)
by flow cytometry. Cells were untreated or treated for
the times indicated with fluorescent dextrans (1 mg/ml) in
the presence or absence of LPS (1 mg/ml). Cell-associated
fluorescence intensity was then compared between
LPS-treated and untreated cell populations to determine
changes from the steady state levels of macropinocytosis.
Note that both CD14 and TLR4 are required for LPS-
induced macropinocytosis. (C) MEFs or A20 B cells were
untreated or treated for the times indicated with fluores-
cent dextrans (1 mg/ml) in the presence or absence of LPS
(1 mg/ml). Cell associated fluorescence intensity was then
compared between LPS-treated and untreated pop-
ulations of cells to determine changes from the steady
state levels of macropinocytosis.Collectively, these data suggest that during DC maturation, the
functions of the TLR4 signaling pathways are not just retained
but enhanced, and that CD14 expression is rate limiting in the
control of TLR4 endocytosis and TRIF signaling.
The Primary Function of CD14 in TRIF Signaling Is to
Deliver TLR4 to Endosomes
We reasoned that if the primary function of CD14 in mediating
TRIF signaling is to promote TLR4 endocytosis, then delivering
TLR4 to endosomes independently of CD14 should restore IFN
expression in CD14-deficient cells. In contrast, if CD14 must
physically change the conformation of TLR4 to permit TRIF
signaling (Jiang et al., 2005), then altering TLR4 localization
would not restore IFN expression to CD14-deficient cells. This
prediction was tested by taking advantage of the fact that
some TLRs will be nonspecifically internalized into phagosomes
(Underhill et al., 1999). Thus, whole E.coli bacteria was used as
an alternative source of LPS. BMDM and DCs derived from
WT, CD14-deficient and TLR4-deficient mice all internalized
E.coli to similar extents (Figures 5A and 5B), and the expression
of MyD88-dependent TNFa was similar in WT and CD14-defi-
cient cells (Figures 5C and 5E). TLR4-deficient cells produced
no cytokines or IFNs in response to E.coli (Figures 5C and 5E).
Interestingly, E.coli treatment induced TLR4 endocytosis and
IFN expression in both WT and CD14-deficient DCs (Figures
5C and 5D). Similarly, LPS-coated latex beads induced the
endocytosis of TLR4 in WT and CD14-deficient DCs (Figures
5G and 5H). Although the total percent of TLR4 internalized using
LPS-coated beads was low when compared to soluble LPS,
these particles restored IFN expression to CD14-deficient DCs872 Cell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc.to a level comparable to WT cells (Figures 5G
and 5H). These data indicate that in DCs, the
primary function of CD14 in IFN expression is
to deliver TLR4 to endosomes where TRIF-
dependent signaling can occur.
The ability of phagocytic cargo to bypass the
need for CD14 in promoting IFN expression
was not universal, however. In contrast to DCs,
phagocytic particles were unable to induce IFN
expression in CD14-deficient BMDM (Figures
5E and 5F). To explain these cell type specificdifferences, we determined if TLR4 was internalized by CD14-
deficient BMDM upon exposure to beads or E.coli. Unlike DCs,
TLR4 surface levels remained constant in CD14-deficient
BMDM treated with either E.coli or LPS-coated beads (Figure 5F
anddatanot shown). Interestingly, thedifferencebetweenBMDM
and DCs in their ability to internalize TLR4 during phagocytosis
wasnotunique to this receptor.Under similar experimental condi-
tions, FcgR1 was also internalized by DCs, but not BMDM, even
though no opsonin was used in these studies (Figure S3A). These
data suggest that DCs are intrinsically more ‘‘permissive’’ than
BMDM in terms of allowing receptors to enter the cell during
phagocytosis. While the molecular basis for this distinction
remains unknown, these observations provide a plausible expla-
nation for why LPS-coated particles can rescue the transport and
signaling defects of CD14-deficient DCs but not BMDM.
CD14 Induces a Syk/PLCg2-Dependent Endocytosis
Pathway that Promotes the Internalization of TLR4
Wesought to identify regulatorsofCD14-dependent endocytosis.
To determine if TLR4 signaling was required for its own transport,
TLR4 endocytosis was examined in cells lacking individual TIR
domain containing adaptors (Akira and Takeda, 2004). The endo-
cytosisof TLR4wasunaffectedby the lackofMyD88,TRIF,TIRAP
or TRAM in DCs or BMDM (Figure S4A and data not shown). In
addition, cells lacking MyD88 and TRIF, which are defective for
all TLR4-dependent activities (Hirotani et al., 2005), retained the
ability to internalize TLR4 in response to LPS (Figure 6A). Similar
results were obtained when examining TLR4 endocytosis in
DCs or BMDM derived from the C3H/HeJ mouse (Figure 6A),
which contain a point mutation in the TLR4 TIR domain that
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Figure 4. The CD14-Dependent Endocytosis Pathway Is Upregulated during DC Maturation
(A) DCs were untreated or treated for 18 hr with CpG DNA (1 mM) or TNFa (100 pg/ml). DC maturation was then assessed by flow cytometry by determining the
increase in surface staining of CD86, CD40, or MHC class II.
(B) Immature DCs or DCs matured for 18 hr with CpG DNA (1 mM) or TNFa (100 pg/ml) were treated with LPS (1 mg/ml) and TLR4 endocytosis was measured by
flow cytometry at the times indicated. Displayed are the MFIs of specific surface TLR4 staining at each time point.
(C and D) Immature DCs or DCs matured for 18 hr with CpG DNA (1 mM) or TNFa (100 pg/ml) were treated with LPS at the concentrations indicated and the
production of the indicated cytokines were measured after 18 hr.
(E) DCs were either untreated or treated for 18 hr with CpG DNA (1mM) or TNFa (100 pg/ml) and the effect of these stimuli on the cell surface levels of CD14 was
assessed by flow cytometry.
(F) DCs of the genotypes indicated were processed as described in (E). After 18 hr, CD14 mRNA levels were determined by qPCR.
(G) DCs were stimulated with the ligands indicated as described in (E) in the presence of absence of the NF-kB inhibitor Bay11-7085 and then processed to
measure CD14 expression by qPCR.abolishes its signaling potential (Poltorak et al., 1998). Thus,
neither a signaling competent TIR nor the signaling adaptor pro-
teins are necessary for LPS-induced TLR4 endocytosis.These data suggest the existence of an LPS-inducible endo-
cytic process that is CD14-dependent but TLR4-signaling inde-
pendent. Upon LPS treatment, CD14 can act independently ofCell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc. 873
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Figure 5. The Requirement of CD14 for TLR4 Endocytosis Can Be Bypassed with Phagocytic Cargo
(A and B) The cells indicated were treated for the times indicated with fluorescent bacteria at a multiplicity of infection (MOI) of 10. Phagocytosis was then
measured at each time point by determining the mean fluorescence intensity (MFI) of the cell populations by flow cytometry.
(C) DCs were treated with E.coli at the MOIs indicated on the x axis, and the production of the indicated cytokines were measured after 18 hr.
(D) DCs were treated with E.coli at anMOI of 10 or LPS (1 mg/ml) and TLR4 endocytosis wasmeasured by flow cytometry at the times indicated. Displayed are the
MFIs of specific surface TLR4 staining at each time point.
(E) BMDM were treated with E.coli at the MOIs indicated on the x axis, and the production of the cytokines indicated were measured.
(F) BMDMwere treated with E.coli at an MOI of 10 or LPS (1 mg/ml) and TLR4 endocytosis was measured by flow cytometry at the times indicated. Displayed are
the MFIs of specific surface TLR4 staining at each time point.
(G) DCs were treated with either LPS-coated latex beads or uncoated beads and the production of the cytokines indicated were measured. (H) DCs were treated
with either LPS-coated latex beads or uncoated beads in the presence of soluble LPS and TLR4 endocytosis was measured by flow cytometry at the times
indicated. Displayed are the MFIs of specific surface TLR4 staining at each time point.
See also Figure S3.
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Figure 6. Role of Syk and PLCg2 in Regulating the CD14-Dependent Endocytosis of TLR4
(A) Immortal BMDMor primary macrophages and DCs of the genotypes indicated were either untreated or treated with LPS (1 mg/ml) for the times indicated. Flow
cytometry was then used to examine receptor endocytosis by determining the surface levels of the endogenous TLR4. Shown are the MFIs of specific TLR4
surface staining at each time point indicated.
(B and C) BMDM (B) or DCs (C) of the genotypes indicated were treated with 10 ng/ml LPS for the times indicated and the rate of TLR4 endocytosis was assessed
by flow cytometry (first panel). Second and third panels: cells were stimulated with 10 ng/ml LPS for 18 hr and the amounts of secreted cytokines were
determined.
(D) The cells indicated were treated with the Src inhibitor in the presence or absence of LPS (10 ng/ml) and the rate of TLR4 endocytosis was monitored by flow
cytometry.
(E) BMDM were treated with the Syk inhibitor piceatannol (75 mM) and were then stimulated with 10 ng/ml LPS. At the times indicated, the rate of TLR4
endocytosis was assessed by flow cytometry (first panel). Second and third panels: cells were stimulated in the presence or absence of piceatannol with 10 ng/ml
LPS for 18 hr, and the amounts of secreted cytokines were determined. Fourth panel: BMDM were treated with LPS (1 mg/ml) for 30 min in the presence or
absence of piceatannol (75 mM). The presence of dimerized IRF3 and IkBa was assessed by western analysis.
(F) BMDM of the genotypes indicated were treated with 10 ng/ml LPS for either 30 or 90 min. The rate of TLR4 endocytosis was assessed by flow cytometry
(first panel). Second and third panels: cells were stimulated with 10 ng/ml LPS for 18 hr, and the amounts of secreted cytokines were determined.
See also Figure S4.
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TLR4 to induce the influx of Ca2+ from the extracellular environ-
ment (Zanoni et al., 2009). This process is mediated by the
enzyme PLCg2. PLCg2 is a regulator of endocytosis (Botelho
et al., 2000; Depoil et al., 2009) and is thus a candidate regulator
of TLR4 endocytosis. To determine if PLCg2 is involved in TLR4
endocytosis, we examined the transport of the receptor in cells
lacking PLCg2. When compared to WT cells, PLCg2-deficient
BMDM and DCs were defective for LPS-induced TLR4 endocy-
tosis (Figures 6B and 6C), although the defect was not as
profound as that observed in CD14-deficient cells. Similar
results were obtained in WT cells treated with the PLC-specific
inhibitor U73122 (Figures S4B and S4C). This defect in TLR4
transport was most impressive at early time points after LPS
treatment, suggesting that PLCg2 regulates the primary pathway
of TLR4 endocytosis and may therefore be important for sig-
naling events that occur from endosomes. Consistent with this
prediction, PLCg2-deficient cells, or WT cells treated with the
PLC inhibitor, were deficient in IFN expression (Figures 6B and
6C and Figures S4B and S4C). TNFa production was unaffected
by the lack of PLCg2. Overall these results largely phenocopy
those obtained with CD14-deficient cells and thus implicate
PLCg2 in CD14-dependent endocytosis.
As Src family members provide a molecular link between
CD14 and PLCg2 for LPS-induced Ca2 mobilization (Zanoni
et al., 2009), we determined if TLR4 endocytosis was sensitive
to chemical inhibitors of this kinase family. Src inhibitors did
not effect TLR4 endocytosis (Figure 6D). We also ruled out a
role for extracellular Ca2, as experiments performed in the pres-
ence of the Ca2 chelator EGTA did not prevent TLR4 endocytosis
(data not shown). Thus, the CD14-dependent/TLR4-indepen-
dent responses described previously (Zanoni et al., 2009) are
distinct from those that lead to TLR4 endocytosis.
In addition to theSrc family, the tyrosine kinaseSyk is upstream
ofPLCg2 (Crowleyet al., 1997;Depoil et al., 2009). Todetermine if
Syk is involved in CD14-dependent endocytosis, WT cells were
treated with two distinct Syk-specific inhibitors, piceatannol
andBay61-3606. Similar to the results obtainedwithPLCg2-defi-
cient cells, treatment with either inhibitor diminished TLR4 endo-
cytosis and IFN production, whereas TNFa expression remained
intact (Figure 6E and Figures S4D and S4E). Moreover, in both
BMDM and DCs, Syk inhibition prevented the LPS-induced
activation of IRF3 but not the degradation of IkB (Figure 6E and
Figure S5A). Thus, like CD14, Syk and PLCg2 are required for
LPS-induced TLR4 endocytosis and signaling from endosomes
but notMyD88-dependent signaling from theplasmamembrane.
Activation of Syk-dependent pathways usually involves a
membrane protein that contains an immunoreceptor tyrosine-
based activation motif (ITAM) (Lowell, 2010). The ITAM contain-
ing transmembrane adaptors DAP12 and FcεRIg are involved in
TLR4 signaling (Chu et al., 2008; Hamerman et al., 2005). Since
CD14 contains neither an ITAM, nor a transmembrane domain,
we considered the possibility that ITAM-containing adaptors
would be necessary for CD14-dependent TLR4 endocytosis.
We examined the transport and signaling of TLR4 in cells lacking
both DAP12 and FcεRIg (Chu et al., 2008). Compared to WT
cells, BMDM and DCs derived from mice doubly deficient in
DAP12 and FcεRIg displayed delayed TLR4 endocytosis and ex-
pressed low levels of TRIF-dependent IFN expression (Figure 6F876 Cell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc.and Figure S5B). MyD88-dependent TNFa expression was unaf-
fected by the lack of ITAM-containing adaptors (Figure 6F and
Figure S5B). These data support the idea that CD14 activates
an ITAM-mediated event that triggers the Syk-PLCg2 mediated
endocytosis of TLR4.
If Syk was truly involved in CD14-dependent endocytosis of
TLR4, then this kinase should be activated by LPS in a manner
dependent on CD14. This was first addressed using western
analysis for the presence of phosphorylated Syk. BMDM stimu-
lated with LPS induced the appearance of phospho-Syk, by
a process dependent on CD14 (Figure 7A). To complement this
approach, we utilized flow cytometry to detect phospho-Syk
after stimulation of cells with either LPS or the known Syk acti-
vator curdlan (Rogers et al., 2005; Underhill et al., 2005). LPS
and curdlan both induced comparable amounts of phospho-
Syk (Figure 7B). Interestingly, Syk-phosphorylation did not occur
in CD14-deficient BMDM or DCs stimulated with LPS, whereas
curdlan-induced Syk-phosphorylation was unaffected by the
lack of CD14 (Figure 7B). Moreover, cells derived from the
C3H/HeJ mouse that harbor a signaling defective TLR4 protein
retained the ability to induce Syk activation (Figure 7B). Collec-
tively, these data demonstrate that Syk is activated by a CD14-
dependent process that does not require TLR4.
Finally, a microscopic approach was used to examine the role
of Syk in CD14-dependent endocytosis. Unfortunately, the anti-
body used to detect TLR4 is not suitable for biochemical or
microscopic techniques. In fact, there are few (if any) antibodies
available that can detect TLR4 reliably. CD14-specific antibodies
are reliable and have been useful tools in many applications. To
determine if CD14 would serve as a marker for Syk-dependent
endocytosis, we examined the requirements for CD14 internali-
zation in response to LPS. Using FACS as a preliminary readout
for CD14 endocytosis, we found that LPS induced CD14 endo-
cytosis by a process independent of TLR4 or its signaling adap-
tors, but was inhibited by Syk or PLC-specific inhibitors (Figures
S5C–S5E). Thus, CD14 and TLR4 are internalized by a similar
process and validate the utility of using CD14 as a marker of
Syk-dependent endocytosis. By confocal microscopy, CD14
labeled the surface of BMDM with a concentration in membrane
ruffles (Figure 7C). Within 3 min of LPS treatment, CD14 ap-
peared in macropinosomes that costained with cholera toxin B
(CTB), which marks GPI rich regions of the plasma membrane
and endosomes (Figure 7C). CD14 and CTB costaining persisted
for up to 30 min, but these endosomes never colocalized exten-
sively with tubular dextran-loaded late endocytic vesicles (Fig-
ure 7C). LPS-induced macropinosomes stained positive for the
early endosomal marker EEA1 (Figure S5F). When cells were
treated with the Syk inhibitor piceatannol, CD14 remained at
the plasma membrane and was poorly internalized (Figure 7C),
and no enlarged EEA1 positive macropinosomes were observed
(Figure S5F). These data are very similar to that obtained by
FACS and thus further validate the existence of a Syk-dependent
endocytic pathway that is triggered by LPS.
DISCUSSION
The role of endocytosis in TLR signaling has attracted much
attention in recent years. Despite its importance, the only known
AB
C
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Figure 7. Syk Is Activated by LPS by a Process Dependent on CD14 but Independent of TLR4
(A) BMDMof the genotypes indicated were stimulated with LPS (100 ng/ml). At the times indicated, the presence of phospho-Syk was examined by western blot.
(B) BMDM and DCs of the genotypes indicated were stimulated with either LPS or curdlan and the presence of phospho-Syk was detected by flow cytometry.
(C) BMDMwere stimulated with LPS (100 ng/ml) for the times indicated and processed for confocal microscopy to detect the presence of CD14, Cholera Toxin B
(CTB) or dextran loaded lysosomes. All images for all panels are representative of at least three independent experiments where over 500 cells were examined per
condition and > 95% of the cells displayed similar staining.
(D) Model depicting a cascade of transport events that is mediated by CD14 in order to promote TLR4 signaling. CD14 first captures and transports LPS to
the plasma membrane localized complex of TLR4 and MD2, which signals through the TIRAP-MyD88 adaptors to activate inflammatory cytokine expression.
CD14 then transports TLR4 to endosomes by a process mediated by Syk and PLCg2, where TRAM-TRIF signaling can lead to the expression of IFNs.
See also Figure S5.
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regulators of TLR endocytosis are dynamins, clathrin and their
associated proteins (Husebye et al., 2006; Kagan et al., 2008).
While these regulators control many general endocytic pro-
cesses, they cannot provide insight into the specific means by
which microbial products can induce TLRs to enter mammalian
cells. Our discovery that the LPS-binding protein CD14 is a regu-
lator of TLR4 endocytosis therefore fills an important gap in our
knowledge of how microbial binding can be coordinated with
TLR endocytosis.
CD14 was identified originally as being important for MyD88-
dependent signal transduction (Moore et al., 2000; Wright
et al., 1990). As many others have reported, we have found
that CD14 is only necessary for MyD88-dependent signaling at
low concentrations of LPS, an observation that is likely explained
by the function of this PRR in transporting LPS to the TLR4-MD-2
complex (da Silva Correia et al., 2001; Gioannini et al., 2004). The
LPS-transport and TLR4-transport functions of CD14 can be
distinguished by the means by which we can bypass their
requirement in TLR4 signaling. For example, while the defects
in MyD88-dependent TNFa expression can be rescued by
increasing the concentration of LPS (Perera et al., 1997), the
defects in TLR4 endocytosis and TRIF signaling cannot. These
data clearly distinguish the two roles of CD14, one in transporting
LPS to the receptor (which can be overcome by increasing LPS
dose) and one in transporting the receptor into the cell (which
can be overcome by forcing the receptor into phagosomes of
DCs). Taken together these data suggest that CD14 initiates
a cascade of trafficking events (Figure 7D). This cascade begins
with CD14 transporting LPS to TLR4 and culminates with CD14
delivering TLR4 to the endosomal signaling machinery that is
needed to induce IFN expression (Figure 7D). This ‘‘innate
immune trafficking cascade’’ may also apply to other nonsignal-
ing PRRs that function to deliver microbial ligands to down-
stream PRRs with signaling capabilities. Since CD36 and the
Mannose Binding Lectin are thought to serve analogous func-
tions to CD14 for TLR2 (Hoebe et al., 2005; Ip et al., 2009), this
suggestion may explain why CD14 is not required for TLR2-
mediated IFN expression.
CD14 is not only required for TLR4endocytosis in naive antigen
presenting cells, but also in mature DCs. When compared to
immature DCs, mature DCs exhibited an enhanced capacity to
internalize TLR4 and induce the expression of TRIF-dependent
genes. All of these activities were dependent on CD14 and
wereobserved inDCsmaturedwith either self-encodedormicro-
bial ligands. These data suggest that CD14-dependent endocy-
tosis is broadly important for the functions of both immature
and mature DCs. In addition, our data reveal that mature DCs
retain the ability to sense and respond to microbial encounters.
CD14 has recently been implicated in regulating the differentia-
tion of monocyte-derived DCs (Mo-DCs) upon encountering
LPS (Cheong et al., 2010). Once differentiated, Mo-DCs express
high levels of CD14 andare potent antigenpresenting cells. Thus,
a trend is emerging whereby mature DCs exhibit higher levels of
CD14 expression than their immature counterparts, and we
suspect that the function of this activity is to enhance the ability
of Mo-DCs to induce T cell differentiation.
For many years, TLR4 has been considered the sole mediator
of CD14-dependent responses because all well-studied activi-878 Cell 147, 868–880, November 11, 2011 ª2011 Elsevier Inc.ties of LPS were dependent on TLR4 and its signaling adaptors.
Thus, after delivery of LPS to TLR4, it is thought that the function
of CD14 is complete and TLR4 can then act independently
of any extracellular factors to promote MyD88 and TRIF sig-
naling. Our discovery that TLR4 actually depends on CD14 for
its own endocytosis represents a significant shift in our under-
standing of the hierarchy of PRRs that regulate responses to
endotoxin. Since TLR4 is cargo for a CD14-dependent endo-
cytic pathway, we propose that TLR4 is not the ‘‘king’’ of all
LPS responses. Rather, TLR4 is subservient to CD14 and
must rely on this upstream PRR to not only receive its ligand
(LPS) but also to be delivered to endosomes where TRIF-medi-
ated signaling can occur. Thus, CD14 sits at the apex of all
cellular responses to LPS and functions to induce an innate
immune trafficking cascade that involves the transport of both
TLR4 and its ligand LPS.
The endocytic pathway activated by CD14 appears to be
ITAM-mediated, and requires Syk and its downstream effector
PLCg2. Evidence in support of this claim comes from observa-
tions that inhibition of either Syk or PLCg2 largely phenocopy
CD14-deficiency. Moreover, our finding that CD14 is necessary
for Syk-activation in response to LPS provides a direct bio-
chemical link between CD14 and this kinase. It is possible that
conditions exist whereby alternative pathways would play a
role in promoting the delivery of TLR4 to endosomes, where
TRIF signaling can occur. In this regard, we would like to
emphasize that our use of the term endosomes does not
exclude a possibility that TLR4 signaling may also occur from
macropinosomes, which can be formed upon LPS treatment
and are likely important in promoting the capture of microbial
products. However, since TRIF signaling can occur from at least
two distinct endosomal vesicles (endosomes and phagosomes),
it is unlikely that TRIF signaling would be restricted to macropi-
nosomes or any specific type of endosome. Rather, we suggest
that the TLR4 network is designed such that any means of
generating a TLR4 containing endosomal vesicle is sufficient
to induce TRIF signaling. The possible number of different
means by which TLR4 can be delivered into endosomes is diffi-
cult to predict, as evidenced by our unexpected finding that
even when using a common means of internalization (phagocy-
tosis), BMDM and DCs differ in their ability allow TLR4 and
FcgR1 to enter phagosomes. Despite this possibility of endo-
cytic heterogeneity, the fact that the CD14-PLCg2-Syk pathway
is activated specifically by LPS suggests that this pathway
represents the primary means of promoting TLR4 internalization
and signaling in cell types as diverse as phagocytes and
fibroblasts.
From an evolutionary perspective, our identification of Syk
and PLCg2 as regulators of LPS-induced endocytosis draws
similarities to other immunity-related endocytosis receptors
that also depend on these factors, such as Dectin-1 and
FcgR1 (Crowley et al., 1997; Rogers et al., 2005; Underhill
et al., 2005). A unifying theme that could link these observations
is the idea of an ‘‘inflammatory endocytosis pathway’’ that is
mediated by Syk/PLCg2 and can be engaged by diverse up-
stream receptors. Our work provides a mandate to consider
the role of this potential inflammatory endocytosis pathway in
diverse pathogenic interactions.
EXPERIMENTAL PROCEDURES
Mice, Cells, and Transfection
C57BL/6 mice were from Harlan-Italy. Cd14/ mice were from CNRS d’Or-
le´ans (Orle´ans Cedex 2, France). OT-II mice were from Charles River. Tlr4/
C57BL/6 mice were provided by S. Akira (Osaka University, Japan). PLCg2
deficient mice were provided by A. Mocsai (Semmelweis University, Hungary).
Bone marrow cells from mice lacking DAP12 and FcεRIg was kindly provided
byM. Colonna (Washington University, St. Louis). All experiments were carried
out in accordance with the relevant laws and institutional guidelines. E. coli
O111 was from ATCC-LGC. DCs and BMDM were derived from bone marrow
of C57BL/6 or mutant mice. DCs were collected after 7–8 days of culture in
10% B16-GM-CSF conditioned medium when CD11c expression, assessed
by flow cytometry, was higher than 90%. BMDM were used after 6 days of
culture in 30% M-CSF conditioned medium. A20 cells and freshly isolated
splenic B cells were transfected with pCDNA3-based vector encoding CD14
by nucleofection (AMAXA) using the Nucleofector Buffer V and program L-013.
Antibodies and Chemicals
Anti-TLR4 antibody (Sa15-21) was labeled with biotin by BioLegend (San
Diego, California). Anti-mouse CD14 was from eBioscience (San Diego, Cali-
fornia) and anti-CD14 was from Miltenyi Biotec. Anti-Phospho-Syk (C87C1)
antibody was from Cell Signaling Technology (Beverly, MA). All the other anti-
bodies and streptavidin-conjugates used for FACS analysis were purchased
from BioLegend (San Diego, California). TLR4-grade LPS (E.Coli, 055:B5)
was from Alexis Biochemicals-Enzo Life Science (Farmingdale, New York).
Recombinant (r)TNF was from R&D Systems (Minneapolis, USA). CpG DNA
(tccatgacgttcctgatgct) was from Primm (Milan, Italy). Curdlan was from
WAKO Pure Chemicals (Osaka, Japan). U73122, Piceatannol, BAY 61-3606
and BAY 11-7085 were from Sigma Aldrich (St. Louis, MO). Fluoresbrite
Carboxy YG 4.5mm latex beads were from Polysciences (Warrington, PA).
For adsorption of LPS onto latex beads, microspheres were resuspended in
LPS (1mg/ml) and incubated overnight at 4C. Latex beads were then washed
15 times in large volumes of sterile endotoxin-free PBS.
Western Blotting
2.5 3 106 cells were subjected to the indicated treatment and lysed with
a buffer containing 1% NP-40, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10%
glycerol, and protease/phosphatase inhibitors (Roche). Cleared lysates were
electrophoresed and immunoblotted with the indicated antibodies using stan-
dard conditions. IRF3 dimerization assay by native page was performed as
described with minor modifications (Iwamura et al., 2001). Briefly, 2.5 3 106
cells were lysed for 150 at 4C with a buffer containing 1% NP-40, 50 mM
Tris-HCl (pH 7.5), 150mMNaCl, 1mMEDTA, protease/phosphatase inhibitors
(Roche), and lysates were cleared by centrifugation at 13,000 3 g for 150 at
4C. Before sample loading, 7% polyacrylamide gels were prerun for 300 at
40mA with 25 mM Tris, 192 mM glycine (pH 8.4) with and without 1% deoxy-
cholate (DOC) in the cathode and anode chamber, respectively. 15mg of
samples in a native sample buffer (10 mg protein, 62.5mM Tris-Cl, pH 6.8,
15% glycerol and 1% DOC) were applied to the gel and electrophoresed for
2-3 hr at 10-15mA. Immunoblotting was performed using standard conditions.
Coimmunoprecipitation
Approximately 2*107 cells were lysed with a buffer containing 1% NP-40,
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10% glycerol and protease/phospha-
tase inhibitors (Roche). After clearing by centrifugation at 16000 x g for 150 at
4C, whole cell extracts (INPUT) were quantified with a BCA kit (ThermoScien-
tific) and 1.5 mg of this fraction were immunoprecipated overnight using
Protein A Sepharose 4 Fast Flow (GE Healthcare) and 1 mg of rabbit anti-
MyD88 (R&D). Immunoprecipated and nonimmunoprecipated material were
referred to as IP and FT (flowthrough), respectively. All fractionswere then sub-
jected to SDS-PAGE and immunoblotting was performedwith anti-MyD88 and
anti-IRAK4 antibodies according to standard procedures.
Cell Purification, Activation, and FACS Staining
B cells were freshly isolated from the spleen of WT animals by positive selec-
tion of CD19+ cells using MACS beads (Miltenyi Biotec). For in vitro stimula-tions, DCs (unstimulated or matured for 18 hr with 1mM CpG or 100pg/ml
rTNFa), BMDM, A20 B cells, freshly isolated splenic B cells and MEFs were
treated with the various concentrations of LPS, E. coli or latex beads at the
appropriate MOI for the times indicated at 37C. Cells were then washed
with ice-cold PBS and stained with the appropriate primary antibodies for
30 min on ice, followed by streptavidin-APC. Staining was assessed with
a FACSCalibur (Becton Dickinson). Syk phosphorylation in DCs and BMDM
treated with LPS (1 mg/ml) or Curdlan (100 mg/ml) was assessed by FACS as
previously described (Underhill et al., 2005). For in vivo stimulations, WT,
CD14-, or TLR4-deficient mice were i.v. injected with 50 mg of LPS and, at
the indicated times, spleens were collected, red-blood cells lysed, and unicel-
lular suspensions stained as described above.
TNFa and IFN Measurements
ELISA for TNFawas performed using the DuoSet kit (R & D, Minneapolis, MN).
IFN activity was measured as described (Dixit et al., 2010).
Real-Time Quantitative PCR
Total RNA was extracted from 3 3 106 cells using the TRIZOL reagent
according to the recommended procedure (GIBCO-BRL). Single-strand
cDNA was synthesized using High-capacity cDNA Reverse Transcription
Kits (Perkin-Elmer, Applied Biosystem Division, Foster City, CA). The Nano-
Drop (TermoScientific) was used to titer mRNA and amplification was per-
formed using the Power Sybr Green PCR Master Mix (Perkin Elmer).
Statistical Analysis
Means were compared by paired or unpaired t tests. Data are expressed and
plotted as means ± ES values. Sample sizes for each experimental condition
are provided in the Experimental Procedures and the figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.cell.2011.09.051.
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